Tri-Pharma
Tri-Pharma is a privately held pharmaceutical wholesaler that sources FDA-approved medications and medical supplies, specializing in drug shortage and backorder fulfillment for hospitals, VA/DOD facilities, oncology clinics, and specialty pharmacies across 44 US states.
- Company typePrivate
- Founded2009
- HeadquartersKennesaw, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Tri-Pharma does
Tri-Pharma is a privately held pharmaceutical wholesale distributor founded in 2009 by Todd Infante and headquartered in Kennesaw, Georgia. The company sources, procures, and delivers FDA-approved prescription medications, IV fluids, blood derivatives, OTC products, and medical supplies to healthcare providers across 44 states, Washington DC, and Puerto Rico. Its core positioning is the secondary pharmaceutical market — filling drug shortages and backorders that primary wholesalers cannot cover — with documented long-term relationships across hospitals, VA medical facilities, DOD facilities, oncology clinics, infusion centers, specialty pharmacies, surgery centers, and correctional facilities.
The company's technology backbone is the proprietary T3/EPCIS platform, a custom ERP system purpose-built for DSCSA compliance. It features direct AS2 connections to 13 third-party serialization providers (including Lspedia, Tracelink, TrackTraceRX, Inmar, and others), enabling sub-five-minute account setup for EPCIS data exchange, full lot/serial-level traceability, recall management workspace, and license validation. Tri-Pharma holds a GS1 Company Prefix (08600108006) and is fully licensed as a wholesale distributor across its covered jurisdictions.
Tri-Pharma operates a sales-led, relationship-driven go-to-market with dedicated account representatives assigned to enterprise healthcare buyers, supplemented by an inside sales team reachable via phone, email, and a website quote form. Pricing is quote-based and not publicly disclosed; payment terms are established via D&B credit checks for new accounts, with ACH, corporate check, and major credit cards accepted. The company does not distribute federal controlled substances and sources exclusively from FDA-approved manufacturers and state-licensed authorized trading partners.
Tri-Pharma firmographics
Firmographics- Name
- Tri-Pharma
- Legal name
- Tri-Pharma, Inc.
- Website
- https://tri-pharma.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Tri-Pharma is a privately held pharmaceutical wholesaler that sources FDA-approved medications and medical supplies, specializing in drug shortage and backorder fulfillment for hospitals, VA/DOD facilities, oncology clinics, and specialty pharmacies across 44 US states.
- Ownership category
- akta.pro rank
Tri-Pharma industry classification
Industry- Product category
- Pharmaceutical Wholesale Distribution
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (424210)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Specialty Pharmaceutical Distributors (HLAIAJAB)
- akta.pro secondary industries
- Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD), Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals (HLAIAJAL)
Keywords
Where Tri-Pharma is headquartered
LocationHeadquarters
- HQ city
- Kennesaw
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Tri-Pharma business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Pharmaceutical Wholesale Distribution: Revenue generated through the sale and distribution of FDA-approved prescription medications, OTC products, IV fluids, blood derivatives, and medical supplies to healthcare providers. Transaction-based pricing with established payment terms including ACH, corporate check, and major credit cards.
- Specialty Pharmaceutical Sourcing: Specialized sourcing of hard-to-find and shortage-listed pharmaceuticals, providing margin opportunity through scarcity pricing during drug shortages.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Transaction based/ take rate | Pay-as-you-go | Quote-based pricing tailored to customer requirements |
Go-to-market motion3 records
Distribution channels2 records
Marketing channels6 records
Tri-Pharma product offering
Product offeringCore offering
Tri-Pharma is a nationwide pharmaceutical wholesaler that sources, procures, and delivers FDA-approved prescription medications, IV fluids, blood derivatives, OTC products, and medical supplies to healthcare providers across the United States. The company specializes in secondary-market sourcing for hard-to-find and shortage-listed pharmaceuticals, supported by a proprietary T3/EPCIS platform for DSCSA-compliant serialization and traceability.
Product overview
Tri-Pharma is a nationwide pharmaceutical wholesaler offering a comprehensive product portfolio spanning five core pharmaceutical categories (Rx Pharmaceuticals, IV Fluids & Solutions, Blood Derivatives, Medical Supplies, and OTC products), complemented by the T3/EPCIS Platform—a proprietary compliance technology for DSCSA traceability. The T3 platform serves as the technological backbone enabling serialization, EPCIS data exchange, and regulatory compliance, while the pharmaceutical products represent the core distribution business.
Differentiator
Problem solved
Functional benefit
Products and services
- Rx Pharmaceuticals FDA-approved prescription medications with assigned National Drug Codes (NDCs), including generic alternatives and specialty pharmaceuticals. Distributed to hospitals, VA/DOD facilities, oncology clinics, infusion centers, specialty pharmacies, and surgery centers.
- IV Fluids & Solutions Intravenous fluids and solutions for medical facilities, shipped in specialized packaging with temperature monitoring to ensure product integrity.
- Blood Derivatives Blood-derived pharmaceutical products distributed to healthcare providers across the United States.
- Medical Supplies Healthcare medical supplies complementing pharmaceutical distribution for complete healthcare provider needs.
- OTC (Over-the-Counter) Over-the-counter medications available for distribution to healthcare providers.
- T3 / EPCIS Platform Proprietary DSCSA-compliant ERP system with AS2 Trading Partner Connections enabling precise tracking of pharmaceutical product movement. Features rapid account setup (under 5 minutes), serialization management, EPCIS capabilities, Transaction Data/Pedigree workspace, Recall Management Workspace, and customer/vendor license validation.
Quantifiable outcome
- 44 states and Washington DC served with pharmaceutical distribution
- +2 more outcomes
Companies that use Tri-Pharma
Customer profileNamed customers9 records
Segments5 records
Ideal customer profiles4 records
Tri-Pharma technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration13 records
Feature6 records
Tri-Pharma partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core.
- LspediacoreThird-party serialization service provider with direct AS2 connection to Tri-Pharma's ERP system for secure real-time data exchange and DSCSA compliance.
- TracelinkcoreThird-party serialization service provider with direct AS2 connection to Tri-Pharma's ERP system for pharmaceutical traceability.
- TrackTraceRXcoreThird-party serialization service provider with direct AS2 connection to Tri-Pharma's ERP system for supply chain visibility.
- InmarcoreThird-party serialization service provider with direct AS2 connection to Tri-Pharma's ERP system for DSCSA compliance.
- CerveycoreThird-party serialization service provider with direct AS2 connection for pharmaceutical track and trace.
- ConsortiEXcoreThird-party serialization service provider with direct AS2 connection for healthcare supply chain compliance.
- MDScriptscoreThird-party serialization service provider with direct AS2 connection to Tri-Pharma's ERP system.
- MovilitascoreThird-party serialization service provider with direct AS2 connection for pharmaceutical compliance.
- RfxcelcoreThird-party serialization service provider with direct AS2 connection for DSCSA compliance management.
- RXVirtualcoreThird-party serialization service provider with direct AS2 connection for pharmaceutical traceability.
- Gateway CheckercoreThird-party serialization service provider with direct AS2 connection for EPCIS data exchange.
- InfinitrakcoreThird-party serialization service provider with direct AS2 connection for supply chain visibility.
- RXScancoreThird-party serialization service provider with direct AS2 connection for pharmaceutical serialization.
- FDA-Approved ManufacturerscoreAuthorized pharmaceutical manufacturers from which Tri-Pharma sources FDA-approved medications. All sourcing is from FDA-approved manufacturers and state-licensed authorized trading partners.
- State Licensed Authorized Trading PartnerscoreNetwork of authorized distributors, manufacturers, and dispensers verified as DSCSA-authorized trading partners for pharmaceutical distribution.
Scale indicators4 records
Recent moves5 records
Expansion highlights4 records
Tri-Pharma competitors and assessment
Company assessmentBroad incumbents
- McKesson: McKesson is one of the Big-3 U.S. pharmaceutical wholesalers and operates a large specialty distribution arm serving hospitals, oncology clinics, and federal facilities. Comparable as the dominant full-line incumbent against which Tri-Pharma positions its secondary-market, shortage-focused offering.
- Cencora (formerly AmerisourceBergen): Cencora is a top-tier pharmaceutical distributor with extensive specialty, community oncology, and federal customer reach. Highly comparable as an incumbent wholesaler whose primary relationships Tri-Pharma complements with secondary-market and shortage sourcing.
- Cardinal Health: Cardinal Health is the third Big-3 wholesaler and operates nuclear pharmacy, specialty, and at-Home Solutions distribution. Comparable as an incumbent with multi-channel pharmaceutical distribution to the same healthcare-provider end customers Tri-Pharma serves.
Emerging players
- RPh Innovations: Secondary-market pharmaceutical wholesaler focused on hard-to-find and shortage SKUs for hospitals and pharmacies. Comparable as a niche competitor in the same secondary/specialty distribution space where Tri-Pharma operates.
Direct peers
- Anda Inc (Teva): Anda is the U.S. distribution arm of Teva, focused on generic, specialty, and pharmaceutical supply to retail pharmacies and health systems. Comparable as a mid-to-large scale wholesaler with a generics/specialty mix overlapping Tri-Pharma's Rx distribution focus.
- H.D. Smith: H.D. Smith was a U.S. pharmaceutical wholesaler with strong specialty, generic, and home healthcare distribution before being acquired. Comparable as a specialty-focused wholesaler serving similar community pharmacy, hospital, and specialty provider segments.
- Smith Drug Company: Smith Drug Company is an independent U.S. wholesaler serving independent pharmacies, hospitals, and long-term care facilities. Comparable mid-sized peer distributing pharmaceuticals and related supplies to the same fragmented healthcare-provider base Tri-Pharma targets.
- Morris & Dickson: Morris & Dickson is a U.S. wholesale distributor focused on full-line and specialty pharmaceutical distribution to hospitals, health systems, and independent pharmacies. Highly comparable mid-sized peer with a similar mix of broad-line distribution and specialty/shortage sourcing into healthcare-provider customers.
Others
- LSPedia: LSPedia is a pharmaceutical serialization and DSCSA compliance platform provider. Comparable as an ecosystem partner and technology enabler—one of the 12+ AS2 connections Tri-Pharma's T3 platform integrates with for serialization data exchange.
- TraceLink: TraceLink is a leading pharmaceutical track-and-trace and supply-chain serialization network used across the industry. Comparable as a critical technology infrastructure provider that Tri-Pharma integrates with via direct AS2 connections to enable DSCSA-compliant trading-partner data exchange.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Tri-Pharma social profiles
Digital presenceTri-Pharma compliance and trust
Trust signalCompliance3 records
Tri-Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tri-Pharma leadership team
Management profileNumber of profiles
Profiles4 records
Tri-Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tri-Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tri-Pharma
What does Tri-Pharma do?
Tri-Pharma is a nationwide pharmaceutical wholesaler that sources, procures, and delivers FDA-approved prescription medications, IV fluids, blood derivatives, OTC products, and medical supplies to healthcare providers across the United States. The company specializes in secondary-market sourcing for hard-to-find and shortage-listed pharmaceuticals, supported by a proprietary T3/EPCIS platform for DSCSA-compliant serialization and traceability.
Is Tri-Pharma a public or private company?
Tri-Pharma is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Tri-Pharma founded?
Tri-Pharma was founded in 2009. It employs 11 to 50 people.
Where is Tri-Pharma based?
Tri-Pharma is headquartered in Kennesaw, United States, in the North America region.
How does Tri-Pharma make money?
Two revenue lines are on record. Pharmaceutical Wholesale Distribution is the primary driver. The others are specialty Pharmaceutical Sourcing.
Who are Tri-Pharma's main competitors?
Broad incumbents on record are McKesson, Cencora (formerly AmerisourceBergen) and Cardinal Health. RPh Innovations is listed as an emerging player. Direct peers are Anda Inc (Teva), H.D. Smith, Smith Drug Company and Morris & Dickson. Others are LSPedia and TraceLink.
Does Tri-Pharma have an API?
No public API is recorded for Tri-Pharma.
What industry is Tri-Pharma in?
Tri-Pharma's product category is Pharmaceutical Wholesale Distribution. Its primary akta.pro industry code is HLAIAJAB, Specialty Pharmaceutical Distributors, with a secondary code of HLAIAJAD, Hospital & Health-System Pharmaceutical Distributors. Its NAICS code is 424210 and its SIC code is 5122.